Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Change in Inventory (2016 - 2025)

Mimedx (MDXG) has disclosed Change in Inventory for 15 consecutive years, with -$1.2 million as the latest value for Q4 2025.

  • Quarterly Change in Inventory fell 164.09% to -$1.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Dec 2025, down 34.96% year-over-year, with the annual reading at $1.5 million for FY2025, 34.96% down from the prior year.
  • Change in Inventory hit -$1.2 million in Q4 2025 for Mimedx, down from $1.6 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $2.9 million in Q1 2024 to a low of -$1.4 million in Q2 2021.
  • Historically, Change in Inventory has averaged $746400.0 across 5 years, with a median of $741500.0 in 2024.
  • Biggest five-year swings in Change in Inventory: crashed 238.7% in 2022 and later surged 918.4% in 2023.
  • Year by year, Change in Inventory stood at $571000.0 in 2021, then plummeted by 238.7% to -$792000.0 in 2022, then soared by 346.59% to $2.0 million in 2023, then crashed by 122.53% to -$440000.0 in 2024, then plummeted by 164.09% to -$1.2 million in 2025.
  • Business Quant data shows Change in Inventory for MDXG at -$1.2 million in Q4 2025, $1.6 million in Q3 2025, and $820000.0 in Q2 2025.